Fundz

Big Picture Bio closes £1.5M pre-seed round led by Kadmos Capital and Exceptional Ventures to develop AI-driven cancer combination therapies.

PRIVATESep 18, 2026

Amount Raised

£1.5 Million

Round Type

Pre-Seed

BiotechnologyHealth CareArtificial IntelligenceMedicalTherapeutics

Investors

Gloucester VenturesJohn WhiteKadmos CapitalExceptional Ventures

Description

Big Picture Bio, a newly founded biotech company, has closed a £1.5 million pre-seed funding round co-led by Kadmos Capital and Exceptional Ventures, with participation from Gloucester Ventures and angel investor John White. The company also received £700,000 in non-dilutive funding from Innovate UK, bringing total support to £2.2 million. Big Picture Bio uses generative AI models to identify and optimize cancer combination therapies by understanding interactions between tumors, immune cells, and surrounding tissue. The platform has been validated against real-world clinical outcomes and has demonstrated predictive accuracy on published trials.

Who to call at Big Picture Bio, and when

A new round usually means Big Picture Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Big Picture Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Big Picture Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Big Picture Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Big Picture Bio

About

Big Picture Bio Ltd. is an AI-driven oncology company that identifies, designs, and optimizes promising cancer combination therapies using a generative world model to understand tumor, immune cell, and tissue interactions. By combining AI-driven modeling with targeted wet lab validation, the company addresses the challenge of identifying drug combinations with higher likelihood of clinical success. The platform has been validated against real-world clinical outcomes and correctly predicted treatment failures. Big Picture Bio aims to transform cancer drug discovery by treating the disease as a dynamic system rather than targeting single pathways.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Big Picture Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Big Picture Bio's next move

See what Strategic adds

Big Picture Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.